Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data NuCana plc files with the SEC in its annual reports.
In GBP millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Research and development
7.9
17.7
16.8
19.7
25.9
36.8
36.4
25.1
18
12.7
General and administrative
1.14
4.57
5.18
5.95
7.05
8.53
7.29
6.06
4.99
8.1
Operating income
-8.45
-25.7
-19.1
-26.7
-36.4
-47.9
-39.1
-32.8
-22.8
-20.1
Interest expense
1.79
0
0
12.6
Interest income
0.28
0.21
1.07
1.05
0.25
0.1
0.67
0.75
0.36
0.39
Pre-tax income
-8.17
-25.5
-18.1
-25.7
-36.2
-47.8
-38.5
-32
-22.5
-30.5
Income tax
-2.12
-2.4
-4.22
-4.24
-5.49
-7.27
-6.43
-4.4
-3.45
-1.17
Income from continuing operations
-6.05
-23.1
Net income
-6.05
-23.1
-13.8
-21.4
-30.7
-40.5
-32
-27.6
-19
-29.4
EPS, basic
-0.25
-0.89
-0.43
-0.66
-0.81
-0.78
-0.61
-0.53
-0.26
0.00
EPS, diluted
-0.25
-0.89
-0.43
-0.66
-0.81
-0.78
-0.61
-0.53
-0.26
0.00
Balance sheet
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
20
86.7
77
52
87.4
60.3
41.9
17.2
6.75
24.3
Receivables
3.05
2.35
4.71
4.63
4.16
3.96
2.67
0.92
0.85
Total current assets
25.8
94
83.6
65.2
102
71.6
54.9
25
12.3
26.9
Property, plant and equipment
0.02
0.36
0.43
1.11
1.19
0.85
0.87
0.52
0.2
0.66
Lease right-of-use assets
0.5
0.5
Intangible assets
1.38
1.94
3.12
3.96
4.75
2.41
2.37
2.13
2.2
2.2
Total assets
27.2
96.4
87.2
70.3
108
77.5
58.3
27.8
14.8
29.8
Total current liabilities
1.97
2.92
5.57
6.18
8.15
11.7
19.3
12.7
8.67
4.79
Lease liabilities
0.54
0.37
0.16
0.4
0.19
0.12
0.66
Total liabilities
1.97
2.94
5.59
6.75
8.56
11.9
19.8
12.9
8.82
5.51
Paid-in capital
42.8
79.2
79.4
79.5
141
141
141
141
146
175
Retained earnings
-22.3
-45.2
-58.8
-80.1
-111
-150
-181
-208
-224
-252
Shareholders' equity
25.2
93.4
Total equity
25.2
93.4
81.6
63.5
99.2
65.5
38.5
14.9
5.95
24.3
Total liabilities and equity
27.2
96.4
87.2
70.3
108
77.5
58.3
27.8
14.8
29.8
Cash flow statement
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-6.05
-23.1
-13.8
-21.4
-30.7
-40.5
-32
-27.6
-19
-29.4
Cash from operations
-9.26
-8.71
-12.2
-23.8
-21.6
-23.8
-23.2
-26.4
-19.1
-7.47
Capital expenditures
-0.02
-0.37
-0.21
-0.05
-0.36
-0.06
-0.01
-0
-0
0
Cash from investing
14.9
-0.93
-0.65
-0.15
-1.31
-3.56
0.12
2.89
0.08
0.16
Stock issued
79.8
66.6
0.25
8.73
20.2
Cash from financing
0.2
77.7
0.21
-0.05
61.8
-0.1
-0.16
-0.05
8.18
25
Exchange rate effect
0.01
-1.39
2.94
-0.99
-3.47
0.39
4.85
-1.08
0.38
-0.2
Net change in cash
5.87
68.1
Free cash flow
-9.28
-9.08
-12.4
-23.9
-22
-23.9
-23.2
-26.4
-19.1
-7.47
Income taxes paid
-1.1
-0.28
-4.22
-0.02
-4.15
-9.89
-7.22
-5.6
-4.02
-3.99
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. No valuation: the share price is quoted in a different currency than the statements.
Profitability
Metric
Value
How it is calculated
Return on assets (ROA)
-131.6%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
Total assets growth, 1y
101.9%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-20.0%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-22.7%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
5.60x
Current assets / current liabilities.
Quick ratio
5.24x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
5.06x
(Cash + short-term investments) / current liabilities.
Liabilities / assets
18.5%
Total liabilities / total assets.
Interest coverage
-1.59x
Operating income / interest expense.
Working capital
£22.1M
Current assets - current liabilities.
Goodwill and intangibles / assets
7.4%
(Goodwill + intangible assets) / total assets.
Per share
Metric
Value
How it is calculated
EPS, diluted
£0.00
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
£0.00
Net income per basic share, as reported (split-adjusted).
Was NuCana plc profitable in fiscal 2025?
No. It reported a net loss of £29.4M.
How much free cash flow did NuCana plc generate in fiscal 2025?
Cash from operations of £7.5M minus capital expenditures of £0.0 left free cash flow of -£7.5M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.